Haemacure Corporation > Message
To commence implementing a financing strategy designed to get back into the clinic for the pivotal Phase II/Phase III clinical trials for its next generation, all-human fibrin sealant during Q1-2009. This is a key date to mark on are calenders.
Post a Reply
Please
login
to reply to this message.